Moderna vax approval continues apace

"Critical laboratory materials” arrive in country as hopes build for availability of new vax alternative With the wider vaccine focus on the paucity of Pfizer's Comirnaty and the abundance of the much-avoided AstraZeneca, work to get Moderna's mRNA vaccine into play locally is quietly moving ahead behind the scenes. The weekend before last AJP learned